Share of Clicks for top 10 US Pharma & Biotech Oncology brands
Here are the Top 10 competitors in the industry by Share of Clicks for the last month.
| Domain | Share of clicks |
|---|---|
| themmrf.org | 5.35 |
| kisqali-hcp.com | 4.68 |
| keytruda.com | 4.52 |
| kisqali.com | 3.85 |
| breyanzi.com | 3.71 |
| mayoclinic.org | 3.34 |
| lilly.com | 2.86 |
| lymphoma.org | 2.62 |
| ibrance.com | 2.35 |
| imbcr.org | 2.06 |
| others | 64.66 |
- themmrf.org - 5.35%
- kisqali-hcp.com - 4.68%
- keytruda.com - 4.52%
- kisqali.com - 3.85%
- breyanzi.com - 3.71%
- mayoclinic.org - 3.34%
- lilly.com - 2.86%
- lymphoma.org - 2.62%
- ibrance.com - 2.35%
- imbcr.org - 2.06%
- others - 64.66%
Copyright © Adthena. All rights reserved.
In the oncology PPC landscape, ‘others’ dominate with 64.66% click share, while themmrf.org leads specific domains at 5.35%.
Share of Spend for the top 10 US Pharma & Biotech Oncology brands
Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month.
| Date | kisqali.com | kisqali-hcp.com | keytruda.com | breyanzi.com | themmrf.org | ibrance.com | lilly.com | lymphoma.org | mayoclinic.org | imbcr.org |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/04/01 | 6.28% | 2.53% | 3.42% | 5% | 10.05% | 0.79% | 2.58% | 4.6% | 3.67% | 4.14% |
| 2026/04/02 | 2.69% | 1.32% | 2.97% | 5.64% | 8.99% | 0.54% | 3.09% | 5.62% | 5.56% | 3.89% |
| 2026/04/03 | 10.51% | 7.68% | 4.84% | 4.1% | 4.63% | 2.49% | 3.57% | 3.39% | 1.91% | 2.98% |
| 2026/04/04 | 11.16% | 8.03% | 4.48% | 3.69% | 3.07% | 2.18% | 3.47% | 1.58% | 2.23% | 2.93% |
| 2026/04/05 | 7.29% | 6.72% | 5.57% | 3.95% | 1.39% | 2.01% | 3.28% | 2.76% | 2.54% | 2.87% |
| 2026/04/06 | 10.32% | 7.18% | 3.51% | 4.25% | 2.44% | 2.67% | 2.58% | 2.63% | 3.68% | 3.3% |
| 2026/04/07 | 9.04% | 6.84% | 4.11% | 3.1% | 2.04% | 4.44% | 3.18% | 3.47% | 3.51% | 1.22% |
| 2026/04/08 | 7.44% | 5.94% | 4.98% | 3.02% | 1.96% | 2.91% | 2.97% | 3.79% | 2.7% | 1.96% |
| 2026/04/09 | 7.48% | 5.51% | 3.55% | 2.85% | 2.61% | 3.4% | 3.96% | 3.6% | 1.48% | 2.58% |
| 2026/04/10 | 11.03% | 6.58% | 4.01% | 2.98% | 2.22% | 2.42% | 3.65% | 2.52% | 2.38% | 2.7% |
| 2026/04/11 | 12.07% | 8.13% | 4.16% | 2.71% | 1.98% | 2.66% | 3.07% | 3.13% | 1.5% | 1.62% |
| 2026/04/12 | 10.93% | 7.05% | 4.16% | 2.74% | 1.88% | 2.86% | 2.7% | 2.68% | 2.58% | 2.52% |
| 2026/04/13 | 9.09% | 6.59% | 4.8% | 2.65% | 4.2% | 3.14% | 3.44% | 1.33% | 2.12% | 2.4% |
| 2026/04/14 | 7.36% | 5.84% | 5.21% | 2.44% | 3.16% | 2.76% | 3.53% | 1.65% | 2.69% | 2.87% |
| 2026/04/15 | 8.61% | 6.18% | 4.62% | 2.13% | 3.81% | 2.23% | 3.45% | 3.03% | 2.67% | 1.05% |
| 2026/04/16 | 11.73% | 7.8% | 4.47% | 2.8% | 4.25% | 3.57% | 3.43% | 2.01% | 1.92% | 0.93% |
| 2026/04/17 | 11.91% | 7.79% | 5% | 1.88% | 9.45% | 2.42% | 2.8% | 1.4% | 1.78% | 2.17% |
| 2026/04/18 | 10.6% | 8.1% | 4.28% | 2.78% | 5.41% | 2.93% | 3.6% | 2.55% | 1.46% | 0.85% |
| 2026/04/19 | 8.84% | 6.03% | 4.86% | 2.61% | 7.13% | 3.26% | 2.76% | 2.11% | 1.18% | 1.51% |
| 2026/04/20 | 8.94% | 6.47% | 4.64% | 2.95% | 5.95% | 2.45% | 2.46% | 1.01% | 2.46% | 1.57% |
| 2026/04/21 | 8.74% | 6.62% | 4.49% | 2.31% | 9.09% | 2.29% | 2.78% | 1.78% | 1.26% | 1.78% |
| 2026/04/22 | 9.81% | 7.1% | 5.2% | 2.79% | 7.19% | 2.1% | 3.27% | 1.6% | 1.42% | 1.33% |
| 2026/04/23 | 8.89% | 6.62% | 4.03% | 2.6% | 8.26% | 2.2% | 2.55% | 2.76% | 1.34% | 2.58% |
| 2026/04/24 | 9.53% | 7.66% | 4.36% | 3.27% | 5.27% | 3.26% | 3.4% | 1.91% | 2.36% | 1.51% |
| 2026/04/25 | 10.6% | 7.99% | 5.13% | 2.54% | 5.31% | 3.13% | 3.48% | 1.13% | 0.99% | 1.62% |
| 2026/04/26 | 9.55% | 7.1% | 5.4% | 3.09% | 6.98% | 2.45% | 2.82% | 1.75% | 1.05% | 1.79% |
| 2026/04/27 | 9.42% | 7.18% | 5.2% | 3.69% | 3.81% | 2.46% | 3.59% | 1.72% | 1.87% | 0.94% |
| 2026/04/28 | 11.43% | 7.97% | 4.52% | 2.85% | 5.3% | 2.37% | 3.51% | 1.97% | 2.11% | 2.28% |
| 2026/04/29 | 10.89% | 7.56% | 4.81% | 2.53% | 3.7% | 2.57% | 3.32% | 2.56% | 2.71% | 2.6% |
| 2026/04/30 | 12.1% | 7.03% | 4.61% | 3.7% | 3.6% | 3.57% | 3.27% | 2.84% | 1.9% | 1.35% |
- kisqali.com
- kisqali-hcp.com
- keytruda.com
- breyanzi.com
- themmrf.org
- ibrance.com
- lilly.com
- lymphoma.org
- mayoclinic.org
- imbcr.org
Copyright © Adthena. All rights reserved.
April saw kisqali.com leading with fluctuating spend, peaking at 12.10% on the 30th. Kisqali-hcp.com followed, maintaining steady growth. Keytruda.com and breyanzi.com showed moderate activity, while themmrf.org experienced a mid-month surge.
Competitor Count for US Pharma & Biotech Oncology
Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month.
| Date | Competitor Count |
|---|---|
| 2026/04/01 | 390 |
| 2026/04/02 | 404 |
| 2026/04/03 | 424 |
| 2026/04/04 | 425 |
| 2026/04/05 | 430 |
| 2026/04/06 | 447 |
| 2026/04/07 | 448 |
| 2026/04/08 | 435 |
| 2026/04/09 | 436 |
| 2026/04/10 | 440 |
| 2026/04/11 | 427 |
| 2026/04/12 | 420 |
| 2026/04/13 | 432 |
| 2026/04/14 | 434 |
| 2026/04/15 | 427 |
| 2026/04/16 | 418 |
| 2026/04/17 | 416 |
| 2026/04/18 | 418 |
| 2026/04/19 | 424 |
| 2026/04/20 | 426 |
| 2026/04/21 | 427 |
| 2026/04/22 | 415 |
| 2026/04/23 | 428 |
| 2026/04/24 | 429 |
| 2026/04/25 | 414 |
| 2026/04/26 | 429 |
| 2026/04/27 | 431 |
| 2026/04/28 | 427 |
| 2026/04/29 | 425 |
| 2026/04/30 | 425 |
Copyright © Adthena. All rights reserved.
April saw a dynamic shift in distinct advertisers, starting at 390 and peaking at 448. The month concluded with a stable 425, reflecting a vibrant advertising landscape.
